» Articles » PMID: 38186849

Psychosocial Issues and Coping Strategies in Families Affected by Long-chain Fatty Acid Oxidation Disorders

Overview
Journal JIMD Rep
Publisher Wiley
Date 2024 Jan 8
PMID 38186849
Authors
Affiliations
Soon will be listed here.
Abstract

Long-chain fatty acid oxidation disorders (lcFAODs) are associated with a high disease burden due to both the risk of metabolic decompensation as well as chronic, partly irreversible complications in some. Little research has been performed on the impact of these disorders on the daily life of parents and caregivers. We performed a web-based questionnaire study among parents/caregivers of patients affected with lcFAODs. The questionnaire focused on challenges at different ages of the child, on disease management issues, schooling, family and social life as well as the parental job situation, and their overall attitude toward the disease and the future life of their child. Data were collected from parents/caregivers of 63 patients (87 respondents, 63% mothers, 36% fathers) with lcFAODs (median age of patients 8.0 years, range 0-25 years, long-chain 3-hydrocyacyl-CoA dehydrogenase deficiency 40%, mitochondrial trifunctional protein deficiency 14%, very long-chain acyl-CoA dehydrogenase deficiency 41%, carnitine palmitoyltransferase 2 deficiency 5%). The overall disease burden of parents was considered highest during infancy and decreased with increasing age of their child. More than one third of parents were afraid that their child's disease might have an impact on his/her career choice and adult life. Negative effects of the child's disease on the job situation and career development were more commonly reported by mothers compared to fathers. Although the majority of parents considered their child's metabolic disorder a severe disease, most parents had a positive attitude toward their child's disease and seemed to cope well with their situation.

Citing Articles

Parental and child's psychosocial and financial burden living with an inherited metabolic disease identified by newborn screening.

Schnabel-Besson E, Garbade S, Gleich F, Grunert S, Kramer J, Thimm E J Inherit Metab Dis. 2024; 48(1):e12784.

PMID: 39189622 PMC: 11670445. DOI: 10.1002/jimd.12784.


Psychosocial issues and coping strategies in families affected by long-chain fatty acid oxidation disorders.

Thiel M, Garbade S, Rosenbaum-Fabian S, Spiekerkoetter U, Grunert S JIMD Rep. 2024; 65(1):25-38.

PMID: 38186849 PMC: 10764200. DOI: 10.1002/jmd2.12402.

References
1.
Lee A, Wolf R, Lebwohl B, Ciaccio E, Green P . Persistent Economic Burden of the Gluten Free Diet. Nutrients. 2019; 11(2). PMC: 6412592. DOI: 10.3390/nu11020399. View

2.
Spiekerkoetter U, Lindner M, Santer R, Grotzke M, Baumgartner M, Boehles H . Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. J Inherit Metab Dis. 2009; 32(4):488-97. DOI: 10.1007/s10545-009-1125-9. View

3.
Khemakhem R, Dridi Y, Hamza M, Ben Hamouda A, Khlayfia Z, Ouerda H . Living with type 1 diabetes mellitus: How does the condition affect children's and adolescents' quality of life?. Arch Pediatr. 2019; 27(1):24-28. DOI: 10.1016/j.arcped.2019.11.002. View

4.
Bani M, Russo S, Raggi E, Gasperini S, Motta S, Menni F . Parents' experience of the communication process of positivity at newborn screening for metabolic diseases: A qualitative study. Child Care Health Dev. 2023; 49(6):961-971. DOI: 10.1111/cch.13105. View

5.
Zeltner N, Landolt M, Baumgartner M, Lageder S, Quitmann J, Sommer R . Living with Intoxication-Type Inborn Errors of Metabolism: A Qualitative Analysis of Interviews with Paediatric Patients and Their Parents. JIMD Rep. 2016; 31:1-9. PMC: 5388637. DOI: 10.1007/8904_2016_545. View